ACT-385781A (Actelion Epoprostenol)

DRUG2 trials

Sponsors

Actelion

Conditions

Pulmonary Arterial Hypertension

Phase 4

Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401

CompletedNCT01105117

ActelionPulmonary Arterial Hypertension

Start: 2010-05-31End: 2011-12-31Updated: 2012-12-03

Epoprostenol for Injection in Pulmonary Arterial Hypertension

CompletedNCT01105091

ActelionPulmonary Arterial Hypertension

Start: 2010-03-31End: 2011-07-31Updated: 2025-02-04